Literature DB >> 24205908

Risk factors and outcomes associated with surgical site infections after craniotomy or craniectomy.

Hsiu-Yin Chiang1, Aparna S Kamath, Jean M Pottinger, Jeremy D W Greenlee, Matthew A Howard, Joseph E Cavanaugh, Loreen A Herwaldt.   

Abstract

OBJECT: Many studies that have evaluated surgical site infections (SSIs) after craniotomy or craniectomy (CRANI) did not use robust methods to assess risk factors for SSIs or outcomes associated with SSIs. The authors conducted the current study to identify risk factors for SSIs after CRANI procedures and to evaluate outcomes attributed to SSIs.
METHODS: The authors performed a nested case-control study of patients undergoing CRANI procedures between 2006 and 2010 at the University of Iowa Hospitals and Clinics. They identified 104 patients with SSIs and selected 312 controls. They collected data from medical records and used multivariate analyses to identify risk factors and outcomes associated with SSIs.
RESULTS: Thirty-two percent of SSIs were caused by Staphylococcus aureus, 88% were deep incisional or organ space infections, and 70% were identified after discharge. Preoperative length of stay (LOS) ≥ 1 day was the only significant patient-related factor in the preoperative model (OR 2.1 [95% CI 1.2-3.4]) and in the overall model (OR 1.9 [95% CI 1.1-3.3]). Procedure-related risk factors that were significant in the overall model included Gliadel wafer use (OR 6.7 [95% CI 2.5-18.2]) and postoperative CSF leak (OR 3.5 [95% CI 1.4-8.5]). The preoperative SSI risk index, including body mass index, previous brain operation, chemotherapy on admission, preoperative LOS, procedure reason, and preoperative glucose level, had better predictive efficacy (c-statistic = 0.664) than the National Healthcare Safety Network risk index (c-statistic = 0.547; p = 0.004). Surgical site infections were associated with increased LOS during the initial hospitalizations (average increase of 50%) or readmissions (average increase of 100%) and with an increased risk of readmissions (OR 7.7 [95% CI 4.0-14.9]), reoperations (OR 36 [95% CI 14.9-87]), and death (OR 3.4 [95% CI 1.5-7.4]).
CONCLUSIONS: Surgeons were able to prospectively assess a patient's risk of SSI based on preoperative risk factors and they could modify some processes of care to lower the risk of SSI. Surgical site infections substantially worsened patients' outcomes. Preventing SSIs after CRANI could improve patient outcomes and decrease health care utilization.

Entities:  

Mesh:

Year:  2013        PMID: 24205908     DOI: 10.3171/2013.9.JNS13843

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Management and prevention of cranioplasty infections.

Authors:  Paolo Frassanito; Flavia Fraschetti; Federico Bianchi; Francesca Giovannenze; Massimo Caldarelli; Giancarlo Scoppettuolo
Journal:  Childs Nerv Syst       Date:  2019-06-20       Impact factor: 1.475

2.  Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study.

Authors:  Henri Salle; Elise Deluche; Elodie Couvé-Deacon; Anne-Claire Beaujeux; Johan Pallud; Alexandre Roux; Arnaud Dagain; Amaury de Barros; Jimmy Voirin; Romuald Seizeur; Houda Belmabrouk; Leslie Lemnos; Evelyne Emery; Marie-Jeanne Fotso; Julien Engelhardt; Vincent Jecko; Ilyess Zemmoura; Tuan Le Van; Moncef Berhouma; Hélène Cebula; Matthieu Peyre; Pierre-Marie Preux; François Caire
Journal:  Infection       Date:  2020-10-09       Impact factor: 3.553

3.  Risk factors for surgical site infections and assessment of vancomycin powder as a preventive measure in patients undergoing first-time cranioplasty.

Authors:  Kingsley O Abode-Iyamah; Hsiu-Yin Chiang; Nolan Winslow; Brian Park; Mario Zanaty; Brian J Dlouhy; Oliver E Flouty; Zachary D Rasmussen; Loreen A Herwaldt; Jeremy D Greenlee
Journal:  J Neurosurg       Date:  2017-05-12       Impact factor: 5.115

Review 4.  Medical management of brain tumors and the sequelae of treatment.

Authors:  David Schiff; Eudocia Q Lee; Lakshmi Nayak; Andrew D Norden; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-10-30       Impact factor: 12.300

5.  Creation of an Automated Fluorescence Guided Tumor Ablation System.

Authors:  Matthew Tucker; Guangshen Ma; Weston Ross; Daniel M Buckland; Patrick J Codd
Journal:  IEEE J Transl Eng Health Med       Date:  2021-07-21       Impact factor: 3.316

Review 6.  Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis.

Authors:  Emily T Martin; Keith S Kaye; Caitlin Knott; Huong Nguyen; Maressa Santarossa; Richard Evans; Elizabeth Bertran; Linda Jaber
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-27       Impact factor: 3.254

7.  Safety of topical vancomycin powder in neurosurgery.

Authors:  Kalil G Abdullah; H Isaac Chen; Timothy H Lucas
Journal:  Surg Neurol Int       Date:  2016-12-05

8.  Orthopedic implant-associated infections caused by Cutibacterium spp. - A remaining diagnostic challenge.

Authors:  Nora Renz; Stasa Mudrovcic; Carsten Perka; Andrej Trampuz
Journal:  PLoS One       Date:  2018-08-20       Impact factor: 3.240

9.  Prospective Multicenter Surveillance Study of Surgical Site Infection after Intracranial Procedures in Korea : A Preliminary Study.

Authors:  Tae Seok Jeong; Gi Taek Yee
Journal:  J Korean Neurosurg Soc       Date:  2018-08-31

Review 10.  A Comprehensive Review of Skull Base Osteomyelitis: Diagnostic and Therapeutic Challenges among Various Presentations.

Authors:  Muhammad Adnan Khan; Syed Abdul Qader Quadri; Abdulmuqueeth Syed Kazmi; Vishal Kwatra; Anirudh Ramachandran; Aaron Gustin; Mudassir Farooqui; Sajid Sattar Suriya; Atif Zafar
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.